Skip to main content
Fig. 6 | BMC Cardiovascular Disorders

Fig. 6

From: HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity

Fig. 6

Characterization of hiPSC-CMs from MEA recording. (A) Representative Microelectrode array (MEA) recording from WT (a), asymptomatic (b) and symptomatic-CMs (c). Arrow indicates the initiation of triggered arrhythmia in symptomatic CMs. Comparison of beats per minute (B), field potential duration (FPD) (C) corrected FPD (D) and (E) occurrence of arrhythmias from WT, asymptomatic and symptomatic CMs. Numbers in parenthesis represent the number of cells used. Data are presented as mean ± S.E.M.

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us